Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia
Clinical trial NCT04549597 · COMPLETED
Trial details
- NCT number
- NCT04549597
- Sponsor
- Ardelyx
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-20
- Primary completion
- 2021-10-13
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.